🧠 Our latest research paper is out now in BMJ Innovations. The results show how Limbic Access creates clinical efficacy and improves treatment outcomes in NHS Talking Therapies. 📓 Flip through a breakdown of the key takeaways and learn more about the scope of our study.
Limbic’s Post
More Relevant Posts
-
Sarah Zenner-Dolan will provide unique insights as a former pharma executive who has personally experienced several Parkinson disease clinical trials during her keynote session at #PatientsEU2024. Sarah will discuss her experience with all aspects of the trial including trial selection, patient burden and what actions the industry can take to enhance the patient journey. Learn more - https://lnkd.in/gtPN3xZP #PatientsasPartners #ClinicalResearch #ClinicalTrials #PatientVoice #PatientPerspective
To view or add a comment, sign in
-
How much do you know about clinical trials? May is #CancerResearchMonth and Clinical Trials Save Lives! At LACN, we have a robust research program and have many trials available for eligible patients. Ask your doctor about it today! You can also read more about our trials on our website here: https://loom.ly/8Fcx050 #clinicalresearch #cancerresearch #clinicaltrials
To view or add a comment, sign in
-
-
The Expert Perspectives In The Management Of GERD webcast features speakers Colin Howden, MD, Joan Chen, MD, MS, and Michael Vaezi, MD, PhD, MSc, FACG. Tune in for this CME webcast to learn about treatment, limitations of current therapies, and clinical trial data pertaining to GERD. View here: https://loom.ly/B3tAFL4
To view or add a comment, sign in
-
-
There is still time to view and receive credit for the Expert Perspectives In The Management of GERD Webcast! Tune in as GiHF faculty discuss key topics including current treatments, limitations of current therapies, and clinical trial data pertaining to GERD. Watch the webcast here: https://loom.ly/0ItqGpI!
To view or add a comment, sign in
-
-
Executive Director | Translational Medicine Team Lead for Gastrointestinal Malignancies | Nivolumab, Ipilimumab & Relatlimab Programs | Bristol Myers Squibb
In this Nat Rev Clin Oncol Perspective, Drs Hung-Yang Kuo, Kabir Khan & Robert Kerbel describe the rationale for angio-immunotherapy combinations, summarize the outcomes of completed phase III clinical trials, discuss successes versus failures and the potential factors that account for these differences, and suggest future experimental and clinical initiatives for improving patient outcomes using this treatment strategy. https://lnkd.in/eWa2Z-wm
To view or add a comment, sign in
-
-
Clinical trials are the backbone of medical progress, paving the way for life-saving treatments and improved patient care. Every breakthrough treatment started as a clinical trial, from life-saving medications to advanced diagnostics. Clinical trials allow researchers to test the safety and efficacy of potential therapies in a controlled setting. Together, let's celebrate the progress made through clinical research and inspire future advancements in healthcare! #medclinresearch #clinicaltrials #research #clinicaltrialsday
To view or add a comment, sign in
-
-
Supporting sponsors in the identification, selection and implementation of measures that matter to assess treatment efficacy in patients. If you're part of our community, this should ring a bell. Mapi Research Trust collaborates with ICON plc to enhance their full-service approach on Outcome Measures: Clinical Outcome Assessments (COAs and eCOAs), Digital health technologies (DHTs) and additional services such as licensing and translation. Attend Caprice Sassano's talk to learn more about outcome measures. #PatientOutcomes #COAs #OutcomeMeasures #DHT
ICON’s Outcome Measures services support sponsors in the identification, selection and implementation of measures that matter to assess treatment efficacy in patients. Learn more about outcome measures during Caprice Sassano’s session at the Clinical Trial Innovation Summit on 22 October. https://ow.ly/UmyX50TIBa7
To view or add a comment, sign in
-
-
Dr. Libby discusses inflammation in atherosclerosis and his journey from basic science labs to large-scale clinical trials. Watch the DeBakey Bytes video below to learn more https://lnkd.in/gAN7bpYQ, or click the link below for the full-length presentation. https://lnkd.in/gf4RnFne
To view or add a comment, sign in
-
Be a hero in IBS research! Join our clinical trial and help us find new treatments. Your involvement means early access to promising therapies and the chance to make a big difference for many. Here is why your participation is so important 👉https://bit.ly/3Pi1mFR #IBSDresearch #clinicaltrials #volunteerforacause #promisingtreatments #exploringnewhorizons #qualityresearch
To view or add a comment, sign in
-
Successfully bringing innovative precision medicines to market requires comprehensive clinical strategies that move these therapies from discovery to clinic. Importantly, it also entails deliberate inclusion of key stakeholders along the entire value chain, from suppliers through to patients. Dive deeper into the considerations for precision medicine in rare disease trials in our therapeutic spotlight: https://ow.ly/67Yn50TFljF
To view or add a comment, sign in
-
🧠 https://limbic.ai/research/improved-recovery